![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
Public release date: 8-May-2012[ | E-mail |
Share ] Contact: Rachel Salis-Silverman
Salis@email.chop.edu
267-426-6063
Children's Hospital of Philadelphia
Childhood cancer expert at the Children's Hospital of Philadelphia to be honored at ASCO Annual Meeting
Yal P. Moss, M.D., who cares for patients with cancer at The Children's Hospital of Philadelphia, will receive the inaugural James B. Nachman ASCO Junior Faculty Award in Pediatric Oncology. The American Society of Clinical Oncology will honor Dr. Moss with this special merit award during its annual meeting, occurring June 1-5 in Chicago.
The new award honors the legacy of Dr. James B. Nachman, a pediatric oncologist and Professor of Pediatrics at the University of Chicago. Dr. Nachman died unexpectedly in 2011 while on a rafting trip in the Grand Canyon with adolescents and young adults who had been under his treatment for cancer.
The Nachman Award committee chose Dr. Moss in recognition of outstanding research that she will present at the ASCO meeting next month. A clinician and researcher with a special focus on the childhood cancer neuroblastoma, Dr. Moss has helped achieve groundbreaking advances in treatment of this disease. In 2008 she led a research team at Children's Hospital that discovered mutations in a gene that occurs in 10 to 15 percent of neuroblastoma cases. That scientific finding provided the impetus for a national clinical trial, currently in progress, of a new drug treatment for neuroblastoma.
Dr. Moss received her M.D. from the Sackler School of Medicine, Tel Aviv, Israel, in 1997, joining The Children's Hospital of Philadelphia residency program that year, followed by fellowship training at the same hospital starting in 2000. She became an attending oncologist at Children's Hospital in 2003 and is also an assistant professor of Pediatrics at the Perelman School of Medicine of the University of Pennsylvania.
###
About The Children's Hospital of Philadelphia: The Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country, ranking third in National Institutes of Health funding. In addition, its unique family-centered care and public service programs have brought the 516-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu.
[ | E-mail | Share ] ?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Public release date: 8-May-2012[ | E-mail |
Share ] Contact: Rachel Salis-Silverman
Salis@email.chop.edu
267-426-6063
Children's Hospital of Philadelphia
Childhood cancer expert at the Children's Hospital of Philadelphia to be honored at ASCO Annual Meeting
Yal P. Moss, M.D., who cares for patients with cancer at The Children's Hospital of Philadelphia, will receive the inaugural James B. Nachman ASCO Junior Faculty Award in Pediatric Oncology. The American Society of Clinical Oncology will honor Dr. Moss with this special merit award during its annual meeting, occurring June 1-5 in Chicago.
The new award honors the legacy of Dr. James B. Nachman, a pediatric oncologist and Professor of Pediatrics at the University of Chicago. Dr. Nachman died unexpectedly in 2011 while on a rafting trip in the Grand Canyon with adolescents and young adults who had been under his treatment for cancer.
The Nachman Award committee chose Dr. Moss in recognition of outstanding research that she will present at the ASCO meeting next month. A clinician and researcher with a special focus on the childhood cancer neuroblastoma, Dr. Moss has helped achieve groundbreaking advances in treatment of this disease. In 2008 she led a research team at Children's Hospital that discovered mutations in a gene that occurs in 10 to 15 percent of neuroblastoma cases. That scientific finding provided the impetus for a national clinical trial, currently in progress, of a new drug treatment for neuroblastoma.
Dr. Moss received her M.D. from the Sackler School of Medicine, Tel Aviv, Israel, in 1997, joining The Children's Hospital of Philadelphia residency program that year, followed by fellowship training at the same hospital starting in 2000. She became an attending oncologist at Children's Hospital in 2003 and is also an assistant professor of Pediatrics at the Perelman School of Medicine of the University of Pennsylvania.
###
About The Children's Hospital of Philadelphia: The Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country, ranking third in National Institutes of Health funding. In addition, its unique family-centered care and public service programs have brought the 516-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu.
[ | E-mail | Share ] ?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
celebrity wife swap gla republican candidates mike martz hokies quadrantid norv turner
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.